| Overview and controversies in the medical management of pit viper envenomation in the dog. | |
| | |
MedLine Citation:
|
PMID: 22316194 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
OBJECTIVE: To provide a review and update on the medical management of pit viper envenomation in dogs. ETIOLOGY: Pit viper snake (Crotalidae) envenomation in dogs is a common emergency in the United States. At least 50 enzymes contribute to snake venom potency that causes soft tissue damage, vasculotoxicity, coagulopathy, cytotoxicity, and necrosis. DIAGNOSIS: Snakebite envenomation may be identified by fang puncture wounds but primarily as a focal site with a rapid onset of severe swelling, hemorrhage, pain, and potentially necrosis. Crotalid venom causes hematologic abnormalities, local tissue damage, hypotension, and occasionally neurological impairment. The most marked hematologic abnormalities include thrombocytopenia, hemolytic anemia, and various forms of coagulopathy, including defibrination without disseminated intravascular coagulation (in North America), summarized as a venom-induced coagulopathy. THERAPY: The mainstay of treatment includes intravenous crystalloid fluid therapy, antivenom, and analgesic medications. Currently available antivenom products include a mixed polyvalent Antivenin (Crotalidae) Polyvalent (ACP(a)), and Crotalinae polyvalent immune Fab (Crofab(b)). There are products from Mexico and Costa Rica that have limited availability, a similar imported Fab product (Antivipmyn(c)), and a polyspecific antivenom (Polyvet-ICP(d)), respectively. Glucocorticoids, nonsteroidal antiinflammatory drugs (NSAIDs) and antihistamines are not included in the majority of recommended treatment protocols by world authorities; however, there are some reports that describe their use. Antimicrobial therapy and blood products are used only when clinically indicated. There is a vaccine available, but at present, it is of unknown efficacy because of a lack of documented scientific information. PROGNOSIS: Mortality from North American crotalid envenomation is generally rare and is influenced by several variables, including the amount of venom injected, the size and species of snake, the size of the victim, the location of the bite, time elapsed until treatment, and the therapy initiated. Mortality rates range from 1% to 30%. |
| | |
Authors:
|
Robert A Armentano; Michael Schaer |
Related Documents
:
|
5725384 - Oxygen-18 content of atmospheric precipitation during last 11,000 years in the great la... 16806404 - Nature and extent of the exposure to fibrous amphiboles in biancavilla. 10810164 - Croatian medical journal at the turn of the millennium. 19967224 - Nursing journals and medication management: identification and categorization of public... 15081884 - Characteristics of illness intrusions in a non-clinical sample. 8947774 - A decision-supported outpatient practice system. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001) Volume: 21 ISSN: 1476-4431 ISO Abbreviation: J Vet Emerg Crit Care (San Antonio) Publication Date: 2011 Oct |
Date Detail:
|
Created Date: 2012-02-09 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101152804 Medline TA: J Vet Emerg Crit Care (San Antonio) Country: United States |
Other Details:
|
Languages: eng Pagination: 461-70 Citation Subset: IM |
Copyright Information:
|
© Veterinary Emergency and Critical Care Society 2011. |
Affiliation:
|
Department of Small Animal Clinical Sciences, University of Florida Small Animal Hospital, Gainesville, FL, 32610. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Unusual Isomeric Corniculatolides from Mangrove, Aegiceras corniculatum.
Next Document: A review of current indications, adverse effects, and administration recommendations for intravenous...